Charlotte Macron
Research Subjects
Charlotte Macron has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Loïc Dayon
Nestlé Institute of Food Safety and Analytical Sciences, Nestlé Research, Lausanne, Switzerland
5 shared publications Antonio Núñez Galindo
Proteomics, Nestlé Institute for Food Safety & Analytical Sciences, Nestlé Research, 1015 Lausanne, Switzerland
4 shared publications- Lydie Lane
CALIPHO Group, SIB Swiss Institute of Bioinformatics and University of Geneva, 1015 Lausanne, Switzerland
2 shared publications - Antonio Núñez Galindo
Nestlé Institute of Food Safety & Analytical Sciences Nestlé Research Lausanne Switzerland
1 shared publication Charles Pineau
Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail)-UMR_S 1085, 35042 Rennes cedex, France
1 shared publicationFrancesco Ferraro
Nestlé Institute of Health Sciences , Lausanne 1015 , Switzerland
1 shared publication
Latest Publications
- 26 March 2021
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 20 (5) , 2283-2290
Proteomics of Human Milk: Definition of a Discovery Workflow for Clinical Research Studies
Milk is a complex biological fluid composed mainly of water, carbohydrates, lipids, proteins, and diverse bioactive factors. Human milk represents a unique tailored source of nutrients that adapts during lactation to the specific needs of the developing infant. Proteins in milk have been studied for decades, and proteomics, peptidomics, and glycoproteomics are the main approaches previously deployed to decipher the proteome of human milk. In the present work, we aimed at implementing a highly automated pipeline for the proteomic analysis of human milk with liquid chromatography mass spectrometry (MS). Commercial human milk samples were used to evaluate and optimize workflows. Centrifugation for defatting milk samples was assessed before and after reduction, alkylation, and enzymatic digestion of proteins, without and with presence of surfactants. Skimmed milk samples were analyzed using isobaric labeling-based quantitative MS on an Orbitrap Tribrid mass spectrometer. Sample fractionation using isoelectric focusing was also evaluated to more deeply profile the human milk proteome. Finally, the most appropriate workflow was transferred to a liquid handling workstation for automated sample preparation. In conclusion, we have defined and describe herein an efficient highly automated proteomic workflow for human milk sample analysis. It is compatible with clinical research, possibly allowing the analysis of sufficiently large cohorts of samples.
- 26 March 2021
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 20 (5) , 2283-2290
Proteomics of Human Milk: Definition of a Discovery Workflow for Clinical Research Studies
Milk is a complex biological fluid composed mainly of water, carbohydrates, lipids, proteins, and diverse bioactive factors. Human milk represents a unique tailored source of nutrients that adapts during lactation to the specific needs of the developing infant. Proteins in milk have been studied for decades, and proteomics, peptidomics, and glycoproteomics are the main approaches previously deployed to decipher the proteome of human milk. In the present work, we aimed at implementing a highly automated pipeline for the proteomic analysis of human milk with liquid chromatography mass spectrometry (MS). Commercial human milk samples were used to evaluate and optimize workflows. Centrifugation for defatting milk samples was assessed before and after reduction, alkylation, and enzymatic digestion of proteins, without and with presence of surfactants. Skimmed milk samples were analyzed using isobaric labeling-based quantitative MS on an Orbitrap Tribrid mass spectrometer. Sample fractionation using isoelectric focusing was also evaluated to more deeply profile the human milk proteome. Finally, the most appropriate workflow was transferred to a liquid handling workstation for automated sample preparation. In conclusion, we have defined and describe herein an efficient highly automated proteomic workflow for human milk sample analysis. It is compatible with clinical research, possibly allowing the analysis of sufficiently large cohorts of samples.
- Open Access
- 1 August 2020
- Published by Elsevier in Data in Brief
- Vol. 31, 105704
Exploration of human cerebrospinal fluid: A large proteome dataset revealed by trapped ion mobility time-of-flight mass spectrometry
- 1 August 2020
- Published by Elsevier in Data in Brief
- Vol. 31, 105704
Open AccessExploration of human cerebrospinal fluid: A large proteome dataset revealed by trapped ion mobility time-of-flight mass spectrometry
- 20 August 2018
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 17 (12) , 4113-4126
Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification
- 20 August 2018
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 17 (12) , 4113-4126
Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification
- 14 August 2018
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 17 (12) , 4315-4319
Identification of Missing Proteins in Normal Human Cerebrospinal Fluid
The cerebrospinal fluid (CSF) proteome dataset presented herein was obtained after immunodepletion of abundant proteins and off-gel electrophoresis fractionation of a commercial pool of normal human CSF; liquid chromatography tandem mass spectrometry analysis was performed with a linear ion trap-Orbitrap Elite. We report the identification of 12344 peptides mapping on 2281 proteins. In the context of the Chromosome-Centric Human Proteome Project (C-HPP), the existence of seven missing proteins (MPs) is proposed to be validated. This dataset is available to the ProteomeXchange Consortium (http://www.proteomexchange.org/) with the dataset identifier PXD008029.
- 14 August 2018
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 17 (12) , 4315-4319
Identification of Missing Proteins in Normal Human Cerebrospinal Fluid
The cerebrospinal fluid (CSF) proteome dataset presented herein was obtained after immunodepletion of abundant proteins and off-gel electrophoresis fractionation of a commercial pool of normal human CSF; liquid chromatography tandem mass spectrometry analysis was performed with a linear ion trap-Orbitrap Elite. We report the identification of 12344 peptides mapping on 2281 proteins. In the context of the Chromosome-Centric Human Proteome Project (C-HPP), the existence of seven missing proteins (MPs) is proposed to be validated. This dataset is available to the ProteomeXchange Consortium (http://www.proteomexchange.org/) with the dataset identifier PXD008029.
- 26 April 2018
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 17 (6) , 2165-2173
An Adaptive Pipeline To Maximize Isobaric Tagging Data in Large-Scale MS-Based Proteomics
Isobaric tagging is the method of choice in Mass Spectrometry (MS)-based proteomics for comparing several conditions at a time. Despite its multiplexing capabilities, some drawbacks appear, when multiple experiments are merged for comparison in large sample-size studies, due to the presence of missing values, which result from the stochastic nature of the Data-Dependent Acquisition (DDA) mode. Another indirect cause of data incompleteness might derive from the proteomic-typical data processing workflow that first identifies proteins in individual experiments and then only quantifies those identified proteins, leaving a large number of unmatched spectra with quantitative information unexploited. Inspired by untargeted metabolomic and label-free proteomic workflows, we developed a quantification-driven bioinformatic pipeline (Quantify then Identify – QtI) that optimizes the processing of isobaric Tandem Mass Tag (TMT) data from large-scale studies. This pipeline includes innovative features, such as Peak Filtering with a self-adaptive pre-processing pipeline optimization method, Peptide Match Rescue (PMR), and Optimized Post-Translational Modification (OPTM). QtI outperforms a classical benchmark workflow in terms of quantification and identification rates, significantly reducing missing data while preserving unmatched features for quantitative comparison. The number of unexploited tandem mass spectra was reduced by 77% and 62% for two human cerebrospinal fluid (CSF) and plasma datasets, respectively.
- 26 April 2018
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 17 (6) , 2165-2173
An Adaptive Pipeline To Maximize Isobaric Tagging Data in Large-Scale MS-Based Proteomics
Isobaric tagging is the method of choice in Mass Spectrometry (MS)-based proteomics for comparing several conditions at a time. Despite its multiplexing capabilities, some drawbacks appear, when multiple experiments are merged for comparison in large sample-size studies, due to the presence of missing values, which result from the stochastic nature of the Data-Dependent Acquisition (DDA) mode. Another indirect cause of data incompleteness might derive from the proteomic-typical data processing workflow that first identifies proteins in individual experiments and then only quantifies those identified proteins, leaving a large number of unmatched spectra with quantitative information unexploited. Inspired by untargeted metabolomic and label-free proteomic workflows, we developed a quantification-driven bioinformatic pipeline (Quantify then Identify – QtI) that optimizes the processing of isobaric Tandem Mass Tag (TMT) data from large-scale studies. This pipeline includes innovative features, such as Peak Filtering with a self-adaptive pre-processing pipeline optimization method, Peptide Match Rescue (PMR), and Optimized Post-Translational Modification (OPTM). QtI outperforms a classical benchmark workflow in terms of quantification and identification rates, significantly reducing missing data while preserving unmatched features for quantitative comparison. The number of unexploited tandem mass spectra was reduced by 77% and 62% for two human cerebrospinal fluid (CSF) and plasma datasets, respectively.